The aim of this study was to quantitatively summarize the association between high FoxP3+ Tregs infiltration and clinical outcomes in human CRC, and thereby provided more evidence on the clinical value of FoxP3+ Tregs as a prognostic index and immunotherapeutic target for human CRC. Here, FOXP3 is linked to colorectal carcinoma.